Search

everythinglearnresearchcommunity

for

Search:↓

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Alarmin cytokines are key in controlling skin immunity and inflammation.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

High concentrations of rosemary and thyme extracts can damage thymus tissue and affect immune markers in chick embryos.

Hydrogels combined with extracellular vesicles and 3D bioprinting improve wound healing.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Prompt treatment of tinea capitis with oral antifungals leads to excellent recovery, but delayed care can cause permanent hair loss.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Immunoadsorption successfully treated a man's resistant polymyositis.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Almost all kidney transplant patients had complications from immunosuppressive therapy, with excessive hair growth being the most common.

Patients with skin immune diseases need better education on UV protection to improve compliance.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

Chinese kidney transplant patients often feel high blood pressure, hair loss, and tiredness from their medications, and more distress leads to worse medication adherence.

Skin issues can indicate immune system problems.